CANDRIAM S.C.A. – ImmunoGen, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$13.64M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+6.22%
quarter
ImmunoGen, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +170.22% | 1.79M shares | 8.89M | $4.78 | 2.85M |
| Q2 2022 | share | Increase | 0.00% | 1.05M shares | 4.75M | $4.5 | 1.05M |
| Q4 2021 | share | Decrease | -100.00% | -2.56M shares | -14.53M | $7.45 | 0 |
| Q3 2021 | share | Increase | +4.12% | 101.47K shares | -1.68M | $5.67 | 2.56M |
| Q2 2021 | share | Increase | 0.00% | 2.46M shares | 16.22M | $6.59 | 2.46M |
| Q3 2019 | share | Decrease | -100.00% | -579.21K shares | -1.25M | $2.42 | 0 |
| Q2 2019 | share | Decrease | -49.84% | -575.51K shares | -1.87M | $2.17 | 579.21K |
| Q1 2019 | share | Increase | +13.08% | 133.58K shares | -1.77M | $2.71 | 1.15M |
| Q4 2018 | share | Increase | +7.21% | 68.63K shares | -4.11M | $4.8 | 1.02M |
| Q3 2018 | share | Increase | +37.25% | 258.5K shares | 2.26M | $9.47 | 952.5K |
| Q2 2018 | share | Increase | +16.84% | 100K shares | 504K | $9.73 | 694K |
| Q1 2018 | share | Increase | +4.21% | 24K shares | 2.59M | $10.52 | 594K |
| Q4 2017 | share | 0.00% | 0 shares | -707K | $6.41 | 570K | |
| Q3 2017 | share | 0.00% | 0 shares | 308K | $7.65 | 570K | |
| Q2 2017 | share | Increase | 0.00% | 570K shares | 4.05M | $7.11 | 570K |
| Q2 2016 | share | Decrease | -100.00% | -208K shares | -1.76M | $3.08 | 0 |
| Q1 2016 | share | Decrease | -12.64% | -30.1K shares | -1.46M | $8.52 | 208K |